|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:918-924
© 2006 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
a Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
b Department of Molecular Pathology, School of Allied Health Science, Osaka University Graduate School of Medicine, Osaka, Japan
c Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Received for publication October 23, 2005; revisions received December 19, 2005; accepted for publication January 10, 2006. * Address for reprints: Yoshiki Sawa, MD, PhD, Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine (E1), 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. (Email: sawa{at}surg1.med.osaka-u.ac.jp).
Objective: To overcome problems related to the intramyocardial injection of cells, including cell loss and a limited graft area, we developed a cell delivery system that uses tissue-engineered myoblast grafts grown as sheets. Here, we assessed the feasibility and efficacy of our method in a canine dilated cardiomyopathy model.
Methods: Skeletal myoblasts were incubated on temperature-responsive culture dishes, and the sheets of cells were detached by decreasing the temperature. Twelve dogs were given continuous ventricular pacing at 230 beats/min for 4 weeks; then the myoblast sheets (n = 5) were grafted onto the left ventricular wall or a sham operation was performed (n = 7). The number of cells was adjusted to 1.5
2.5 x 106 cells per graft, and each dog received approximately 20 grafts.
Results: The cell sheets were easily grafted onto a large area of the left ventricular surface, and there were no serious sequelae. Four weeks after graft implantation, echocardiography demonstrated that the left ventricular ejection fraction (graft, 26.0% ± 5.6%; control, 19.5% ± 6.8%; P < .05) and fractional shortening (graft, 17.9% ± 3.6%; control, 7.8% ± 2.1%; P < .05) were significantly ameliorated with reduced left ventricular dilatation (graft, 7.3 ± 1.3 cm2; control, 10.2 ± 0.4 cm2; P < .05) and increased wall thickness (graft, 5.6 ± 0.7 mm; control, 4.4 ± 0.6 mm; P < .05). Histologic evidence indicated the grafted myoblasts had survived, accompanied by a significant reduction in fibrosis and apoptosis, and a significant increase in proliferation.
Conclusions: Grafting of skeletal myoblast sheets attenuated cardiac remodeling and improved cardiac performance. This novel method was feasible and effective in a large animal model, suggesting an innovative and promising strategy for treating patients with end-stage dilated cardiomyopathy.
This article has been cited by other articles:
![]() |
N. Takehara and H. Matsubara Cardiac regeneration therapy: connections to cardiac physiology Am J Physiol Heart Circ Physiol, December 1, 2011; 301(6): H2169 - H2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyagawa, M. Roth, A. Saito, Y. Sawa, and S. Kostin Tissue-Engineered Cardiac Constructs for Cardiac Repair Ann. Thorac. Surg., January 1, 2011; 91(1): 320 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sekiya, G. Matsumiya, S. Miyagawa, A. Saito, T. Shimizu, T. Okano, N. Kawaguchi, N. Matsuura, and Y. Sawa Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 985 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hoashi, G. Matsumiya, S. Miyagawa, H. Ichikawa, T. Ueno, M. Ono, A. Saito, T. Shimizu, T. Okano, N. Kawaguchi, et al. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 460 - 467. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |